JPS57193418A - Manufacture of plasminogen - Google Patents

Manufacture of plasminogen

Info

Publication number
JPS57193418A
JPS57193418A JP57079248A JP7924882A JPS57193418A JP S57193418 A JPS57193418 A JP S57193418A JP 57079248 A JP57079248 A JP 57079248A JP 7924882 A JP7924882 A JP 7924882A JP S57193418 A JPS57193418 A JP S57193418A
Authority
JP
Japan
Prior art keywords
plasminogen
manufacture
plasmin
saccharide
specificity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP57079248A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0366292B2 (enExample
Inventor
Heeberu Herumuuto
Shiyubuin Horusuto
Haimuburugaa Noruberuto
Kumupe Geeruharuto
Shiku Manfureto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of JPS57193418A publication Critical patent/JPS57193418A/ja
Publication of JPH0366292B2 publication Critical patent/JPH0366292B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6435—Plasmin (3.4.21.7), i.e. fibrinolysin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/484—Plasmin (3.4.21.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP57079248A 1981-05-14 1982-05-13 Manufacture of plasminogen Granted JPS57193418A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813119157 DE3119157A1 (de) 1981-05-14 1981-05-14 Verfahren zur herstellung von und danach hergestelltes plasminogen

Publications (2)

Publication Number Publication Date
JPS57193418A true JPS57193418A (en) 1982-11-27
JPH0366292B2 JPH0366292B2 (enExample) 1991-10-16

Family

ID=6132282

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57079248A Granted JPS57193418A (en) 1981-05-14 1982-05-13 Manufacture of plasminogen

Country Status (11)

Country Link
US (1) US4442213A (enExample)
EP (1) EP0065256B1 (enExample)
JP (1) JPS57193418A (enExample)
AT (1) ATE21824T1 (enExample)
AU (1) AU547139B2 (enExample)
CA (1) CA1187411A (enExample)
DE (2) DE3119157A1 (enExample)
ES (1) ES511982A0 (enExample)
IL (1) IL65752A (enExample)
MX (1) MX7033E (enExample)
NZ (1) NZ200589A (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62153224A (ja) * 1985-12-27 1987-07-08 Green Cross Corp:The プラスミノゲン製剤
US4699525A (en) * 1985-07-18 1987-10-13 Ebara Corporation Thrust bearing
JPH04273827A (ja) * 1990-10-11 1992-09-30 Immuno Ag Ｌｙｓ−プラスミノーゲンを含有する医薬
JP2018505209A (ja) * 2014-12-19 2018-02-22 プロメティック・バイオセラピューティクス・インコーポレイテッドＰｒｏＭｅｔｉｃ ＢｉｏＴｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． プラミノーゲンを含む医薬組成物及びその使用

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4604358A (en) * 1983-04-14 1986-08-05 Armour Pharmaceutical Company Preparation of pasteurized human plasminogen
EP0156169B1 (en) * 1984-02-29 1991-12-18 Asahi Kasei Kogyo Kabushiki Kaisha An aqueous solution of a tissue plasminogen activator dissolved therein at an increased concentration and a method
US4857320A (en) * 1987-02-19 1989-08-15 Monsanto Company Method of enhancing the solubility of tissue plasminogen activator
WO1997001631A1 (en) * 1995-06-26 1997-01-16 Daiichi Pure Chemicals Co., Ltd. Stable plasmin solution
US6969515B2 (en) 1999-11-13 2005-11-29 Talecris Biotherapeutics, Inc. Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
US7544500B2 (en) * 1999-11-13 2009-06-09 Talecris Biotherapeutics, Inc. Process for the production of a reversibly inactive acidified plasmin composition
US6964764B2 (en) * 1999-11-13 2005-11-15 Talecris Biotherapeutics, Inc. Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
US6355243B1 (en) 1999-11-13 2002-03-12 Bayer Corporation Method of thrombolysis by local delivery of active plasmin
NZ589557A (en) * 2008-06-04 2012-08-31 Talecris Biotherapeutics Inc Immobilised streptokinase, method and kit for preparing plasmin
ES2552337T3 (es) 2009-03-03 2015-11-27 Grifols Therapeutics Inc. Procedimientos para la preparación de plasminógeno

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52151711A (en) * 1976-04-07 1977-12-16 Choay Sa Aqueous composition with plasminogen activity
JPS55145615A (en) * 1979-04-25 1980-11-13 Behringwerke Ag Blood coagulation factor and its manufacture
JPS56106594A (en) * 1980-01-25 1981-08-24 Green Cross Corp:The Stabilizing method of plasminogen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5716824A (en) * 1980-07-03 1982-01-28 Green Cross Corp:The Plasminogen pharmaceutical and stabilizing method thereof
GB2068002B (en) * 1980-01-25 1983-06-29 Green Cross Corp Plasminogen preparation and their production
FR2504921A1 (fr) * 1981-04-30 1982-11-05 Choay Sa Medicament nouveau constitue par un complexe aprotinine-plasmine et procede de preparation de ce nouveau complexe

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52151711A (en) * 1976-04-07 1977-12-16 Choay Sa Aqueous composition with plasminogen activity
JPS55145615A (en) * 1979-04-25 1980-11-13 Behringwerke Ag Blood coagulation factor and its manufacture
JPS56106594A (en) * 1980-01-25 1981-08-24 Green Cross Corp:The Stabilizing method of plasminogen

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4699525A (en) * 1985-07-18 1987-10-13 Ebara Corporation Thrust bearing
JPS62153224A (ja) * 1985-12-27 1987-07-08 Green Cross Corp:The プラスミノゲン製剤
JPH04273827A (ja) * 1990-10-11 1992-09-30 Immuno Ag Ｌｙｓ−プラスミノーゲンを含有する医薬
JP2018505209A (ja) * 2014-12-19 2018-02-22 プロメティック・バイオセラピューティクス・インコーポレイテッドＰｒｏＭｅｔｉｃ ＢｉｏＴｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． プラミノーゲンを含む医薬組成物及びその使用
JP2021059549A (ja) * 2014-12-19 2021-04-15 プロメティック・バイオセラピューティクス・インコーポレイテッドＰｒｏＭｅｔｉｃ ＢｉｏＴｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． プラミノーゲンを含む医薬組成物及びその使用

Also Published As

Publication number Publication date
JPH0366292B2 (enExample) 1991-10-16
EP0065256A3 (en) 1984-01-18
DE3272987D1 (en) 1986-10-09
ES8303442A1 (es) 1983-02-01
AU8366182A (en) 1982-11-18
EP0065256A2 (de) 1982-11-24
CA1187411A (en) 1985-05-21
NZ200589A (en) 1985-04-30
ATE21824T1 (de) 1986-09-15
EP0065256B1 (de) 1986-09-03
AU547139B2 (en) 1985-10-10
MX7033E (es) 1987-03-03
US4442213A (en) 1984-04-10
DE3119157A1 (de) 1982-12-09
IL65752A0 (en) 1982-08-31
IL65752A (en) 1985-05-31
ES511982A0 (es) 1983-02-01

Similar Documents

Publication Publication Date Title
JPS57193418A (en) Manufacture of plasminogen
ES8307500A1 (es) "metodo para inactivar los virus infecciosos contenidos en una composicion enzimatica hemocoagulante".
DE3160522D1 (en) Agents for the detection of esterolytic and/or proteolytic enzymes; and phenoxy-amino acids and phenoxy-peptide esters suitable as substrates therefor, process for their production and their use in producing the agents
IL64323A (en) Process for the production of hepatitis-safe blood-clotting factors ii and vii
SE7602751L (sv) Framstellning av n-acyl-l-metionin
ES8100763A1 (es) Procedimiento para la preparacion de concentrado de complejoprotrombinico
EP0297597A3 (en) Method for determining the activity of serine proteinases or serine proteinase inhibitors
EP0188262A3 (en) Process for the isolation of chicken egg white cystatine, antiviral agents containing it and its use as viral protease inhibitor
JPS51118820A (en) A process for preparing heat stable macroglobulin
ATE56149T1 (de) Verfahren zum pasteurisieren von fibronectin.
ES309511A1 (es) Procedimiento de fabricacion de un hidrolizado de materias proteicas, particular de levaduras.
JPS5431952A (en) Temperature controller
ES2176349T3 (es) Proceso de sililacion.
DE3479188D1 (en) Methods of stabilizing thimerosal in presence of polyvinylpyrrolidone
GB1047834A (en) Preparation of enzymes
JPS51119319A (en) A process for producing conditioned steel having a good low temperatur e strength
GB1492441A (en) Confirming a desired heat effect on a material
Eremeyev et al. Formal kinetic description of empirical regularities for dissolution of gelatine gels by proteinases.
JPS5249641A (en) Process for fit-work of sheet glass
JPS5238009A (en) Method for the manufacture of hige- activity prophylactic and therapeu tic agent for viral infections
ES378594A1 (es) Un procedimiento de fabricacion de un autolizado de pesca- dos y de materias ictiologicas.
JPS5760642A (en) Manufacture of bulb
JPS529111A (en) Process for shaping nozzle
IT8402503A0 (it) Apparecchio per centratura e campanatura contemporanea di ruote da bicicletta.
GB1055536A (en) Method for the production of lime slagstone